Surya Mohapatra

Currently holds positions in Xylem Inc and Leidos Holdings Inc

2.9

2.9

Position	Company	Period
Independent Director	Xylem Inc	Oct. 31, 2011 -
Independent Director	Leidos Holdings Inc	Aug. 16, 2016 -
Chairman of the Board, President, Chief Executive Officer	Quest Diagnostics Inc	Dec. 14, 2004 - April 30, 2012

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2024-11-12	2024-11-07	Leidos Holdings Inc (LDOS)	S Sale	45,608 +8.2% 121.84 US$3,565,823	45,608 +8.2%	121.84	US$3,565,823
2024-11-07	2024-11-07	Leidos Holdings Inc (LDOS)	PrS Proposed sale	93,260 418.54 US$2,131,572	93,260	418.54	US$2,131,572
2023-11-24	2023-11-22	Leidos Holdings Inc (LDOS)	S Sale	84,968 -33.1% 366.02 US$2,899,870	84,968 -33.1%	366.02	US$2,899,870
2023-11-22	2023-11-22	Leidos Holdings Inc (LDOS)	PrS Proposed sale	4,788 105.83 US$506,723	4,788	105.83	US$506,723
2022-08-22	2022-08-18	Leidos Holdings Inc (LDOS)	S Sale	3,155 -15.3% 101.52 US$320,281	3,155 -15.3%	101.52	US$320,281
2022-02-11	2022-02-09	Xylem Inc (XYL)	B Purchase	245 +0.6% 95.03 US$23,282	245 +0.6%	95.03	US$23,282
2020-02-13	2020-02-11	Xylem Inc (XYL)	S Sale	2,860 -7.1% 86.08 US$246,203	2,860 -7.1%	86.08	US$246,203
2004-05-18	2004-05-17	Quest Diagnostics Inc (DGX)	S Sale	13,400 -19.3% 81.82 US$1,096,336	13,400 -19.3%	81.82	US$1,096,336
2004-05-18	2004-05-14	Quest Diagnostics Inc (DGX)	S Sale	38,900 -35.9% 82.82 US$3,221,616	38,900 -35.9%	82.82	US$3,221,616